Keywords: Prostate, Cancer, tissue sodium concentration; apparent diffusion coefficient; standardized uptake value; androgen deprivation therapy
Motivation: Androgen deprivation therapy (ADT) is used to treat intermediate- to high-risk prostate cancer (PCa) and significantly alters prostate anatomy. However, there are limited imaging studies investigating treatment response on a functional and molecular level.
Goal(s): To assess tissue sodium concentration (TSC) measured by sodium MRI as a biomarker for ADT response in PCa.
Approach: TSC was quantified in 14 participants with PCa using sodium MRI before and after 3 months of ADT. Diffusion-weighted MRI and prostate-specific membrane antigen positron emission tomography (PSMA-PET) were also performed as clinical references.
Results: Increased tumour TSC and decreased PSMA tracer uptake were observed post-ADT.
Impact: For the first time, sodium MRI was used to measure changes in tissue sodium concentration pre- and post-androgen deprivation therapy in patients with prostate cancer. These findings may provide further insight on tumour response to ADT at a molecular level.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords